-
13813-100A tyrosine kinase inhibitor that blocks the activation of VEGFR1, VEGFR2, VEGFR3, c-kit, and PDGFR-&beta (IC<sub>50</sub> = 1.2, 0.
-
13813-50A tyrosine kinase inhibitor that blocks the activation of VEGFR1, VEGFR2, VEGFR3, c-kit, and PDGFR-&beta (IC<sub>50</sub> = 1.2, 0.
-
13813-500A tyrosine kinase inhibitor that blocks the activation of VEGFR1, VEGFR2, VEGFR3, c-kit, and PDGFR-&beta (IC<sub>50</sub> = 1.2, 0.
-
MAG-DYECL-1Excess dye terminator clean-up post sequencing reaction clean-up is an essential step prior to sequencing. The carry over of excess dye into sequencing results in dye blobs which leads to overwhelming noise and failed calls of sequenced bases and
-
MAG-VNA-SHigh throughput extraction of viral nucleic acid (RNA and DNA) from biofluids. Viruses, such as SARS-CoV-2 (COVID-19), can cause serious health issues and play an important role in molecular biology and biomedical research.
-
MAG-VNA-MHigh throughput extraction of viral nucleic acid (RNA and DNA) from biofluids. Viruses, such as SARS-CoV-2 (COVID-19), can cause serious health issues and play an important role in molecular biology and biomedical research.
-
MAG-FRAG-I-1Post DNA shearing, the library construction process for next generation sequencing mostly requires fragment selection regardless of the platform. Obtaining high recovery post fragment selection is becoming an important contributor for the reduction
-
14611-1A DHCR7 inhibitor that prevents cholesterol biosynthesis and Hedgehog signaling used to recapitulate phenotypes of Smith-Lemli-Opitz syndrome, a disorder brought about by mutations in the DHCR7 gene, in animal models.
-
14611-10A DHCR7 inhibitor that prevents cholesterol biosynthesis and Hedgehog signaling used to recapitulate phenotypes of Smith-Lemli-Opitz syndrome, a disorder brought about by mutations in the DHCR7 gene, in animal models.
-
14611-25A DHCR7 inhibitor that prevents cholesterol biosynthesis and Hedgehog signaling used to recapitulate phenotypes of Smith-Lemli-Opitz syndrome, a disorder brought about by mutations in the DHCR7 gene, in animal models.
-
14611-5A DHCR7 inhibitor that prevents cholesterol biosynthesis and Hedgehog signaling used to recapitulate phenotypes of Smith-Lemli-Opitz syndrome, a disorder brought about by mutations in the DHCR7 gene, in animal models.
-
17589-1A potent, selective inhibitor of ATR (IC<sub>50</sub> = 5 nM) inhibits the growth of LoVo colorectal adenocarcinoma cells in vitro and significantly reduces the growth of LoVo xenografts in mice.